322 related articles for article (PubMed ID: 23934444)
1. A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.
Cao L; Lin J; He B; Wang H; Rao J; Liu Y; Zhang X
Tumour Biol; 2014 Jan; 35(1):455-62. PubMed ID: 23934444
[TBL] [Abstract][Full Text] [Related]
2. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1].
Li Z; Tan W; Shao K
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):5-7. PubMed ID: 11776598
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2E1 variable number tandem repeat polymorphisms and health risks: a genotype-phenotype study in cancers associated with drinking and/or smoking.
Catanzaro I; Naselli F; Saverini M; Giacalone A; Montalto G; Caradonna F
Mol Med Rep; 2012 Aug; 6(2):416-20. PubMed ID: 22614694
[TBL] [Abstract][Full Text] [Related]
6. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL
Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074
[TBL] [Abstract][Full Text] [Related]
7. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
Liu R; Yin LH; Pu YP
Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
[TBL] [Abstract][Full Text] [Related]
8. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer.
Wu X; Shi H; Jiang H; Kemp B; Hong WK; Delclos GL; Spitz MR
Carcinogenesis; 1997 May; 18(5):967-73. PubMed ID: 9163682
[TBL] [Abstract][Full Text] [Related]
9. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
[TBL] [Abstract][Full Text] [Related]
10. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population.
Wang J; Deng Y; Li L; Kuriki K; Ding J; Pan X; Zhuge X; Jiang J; Luo C; Lin P; Tokudome S
Cancer Sci; 2003 May; 94(5):448-52. PubMed ID: 12824892
[TBL] [Abstract][Full Text] [Related]
11. CYP2E1 rs2031920, COMT rs4680 Polymorphisms, Cigarette Smoking, Alcohol Use and Lung Cancer Risk in a Japanese Population.
Kakino K; Kiyohara C; Horiuchi T; Nakanishi Y
Asian Pac J Cancer Prev; 2016; 17(8):4063-70. PubMed ID: 27644662
[TBL] [Abstract][Full Text] [Related]
12. CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.
Gao CM; Takezaki T; Wu JZ; Chen MB; Liu YT; Ding JH; Sugimura H; Cao J; Hamajima N; Tajima K
World J Gastroenterol; 2007 Nov; 13(43):5725-30. PubMed ID: 17963298
[TBL] [Abstract][Full Text] [Related]
13. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
14. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.
Iizasa T; Baba M; Saitoh Y; Suzuki M; Haga Y; Iyoda A; Chang H; Hiroshima K; Itoga S; Tomonaga T; Nomura F; Fujisawa T
Oncol Rep; 2005 Oct; 14(4):919-23. PubMed ID: 16142352
[TBL] [Abstract][Full Text] [Related]
16. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Song L; Peng L; Bu Z; Yan SX; Feng J; Zhu XL; Liao XB; Yu XL; Yan D
Mol Genet Genomics; 2015 Apr; 290(2):545-58. PubMed ID: 25336053
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Mol Cell Biochem; 2004 Nov; 266(1-2):1-9. PubMed ID: 15646021
[TBL] [Abstract][Full Text] [Related]
18. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.
Boccia S; De Lauretis A; Gianfagna F; van Duijn CM; Ricciardi G
Carcinogenesis; 2007 Jan; 28(1):101-6. PubMed ID: 16837478
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations.
Wu X; Amos CI; Kemp BL; Shi H; Jiang H; Wan Y; Spitz MR
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):13-8. PubMed ID: 9456237
[TBL] [Abstract][Full Text] [Related]
20. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
